4-(6-Formylpyridin-2-yl)benzonitrile

Catalog No. :
ACBWEC950
CAS No. :
834884-79-6
Molecular Formula :
C13H8N2O
Molecular Weight :
208.22

IUPAC Name:4-(6-formylpyridin-2-yl)benzonitrile

4-(6-Formylpyridin-2-yl)benzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$77.00Login to see priceIn stockIn stock
250mg97%$112.00Login to see priceIn stockIn stock
1g97%$148.00Login to see priceIn stockIn stock
5g97%$706.00Login to see priceIn stockInquiry
25g97%$2824.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(6-Formylpyridin-2-yl)benzonitrile
IUPAC Name4-(6-formylpyridin-2-yl)benzonitrile
MDL No.MFCD07368905
Molecular FormulaC13H8N2O
Molecular Weight208.22
SMILESN#CC1=CC=C(C2=NC(C=O)=CC=C2)C=C1
InChI KeyPPAQGUBYGPCPLW-UHFFFAOYSA-N
Synonym4-(6-Formylpyridin-2-yl)benzonitrile | AKOS015960170 | 4-(6-Formylpyridin-2-yl)benzonitrile, 97% | PPAQGUBYGPCPLW-UHFFFAOYSA-N | 4-(6-FORMYL-(PYRIDIN-2-YL))-BENZONITRILE | DTXSID30584626 | 6-(4-Cyanophenyl)pyridine-2-carbaldehyde | SCHEMBL303840 | MFCD073
CAS No.834884-79-6
PubChem CID16217890

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H315-H319-H335
Precautionary Statement(s)
P261-P301+P310-P305+P351+P338

Synthetic Route by SureRoute

1. ACBWEC950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBWEC950 route product structure diagram
    ACBWEC950834884-79-6 In Stock
Inquiry

2. ACBWEC950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHYWT941 route compound structure diagram
    ACHYWT941126747-14-6 In Stock
  2. Plus
  3. ACRJIX213 route compound structure diagram
    ACRJIX21334160-40-2 In Stock
  4. Then
  5. ACBWEC950 route product structure diagram
    ACBWEC950834884-79-6 In Stock
Inquiry

Comments (0)